or
forgot password
  • cancer clinical trials in new mexico

  • A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)
    New Mexico Cancer Care Alliance
    Albuquerque, New Mexico 87106
    Metastatic Pancreatic Adenocarcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Presbyterian Kaseman Hospital
    San Juan Oncology Associates
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    UNM Eye Clinic
    Memorial Medical Center
    Non Squamous Lung Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates Inc
    Memorial Medical Center - Las Cruces
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Southwest Gynecologic Oncology Associates
    Albuquerque, New Mexico 87106
    Ovarian Cancer
    A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma
    ImClone Investigational Site
    Albuquerque, New Mexico 87131
    Gastric Cancer
    A Study in Second Line Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Albuquerque, New Mexico 87106
    Colorectal Cancer
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    University of New Mexico Cancer Center - South
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Study of PX-866 and Docetaxel in Solid Tumors
    New Mexico Cancer Care Alliance
    Albuquerque, New Mexico 87106
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

    Albuquerque, New Mexico 87131-5636
    Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Lovelace Medical Center - Downtown
    University of New Mexico Cancer Center - South
    Breast Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Hematology Oncology Associates
    Memorial Medical Center - Las Cruces
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Head and Neck Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    University of New Mexico

    Trial Locations
    University of New Mexico
    Hematology Oncology Associates
    University of New Mexico at Lovelace Medical Center
    Presbyterian Kaseman Hospital
    Memorial Medical Center - Las Cruces
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    New Mexico Oncology Hematology Consultants, LTD

    Trial Locations
    New Mexico Oncology Hematology Consultants, LTD
    New Mexico Cancer Care Associates
    Advanced Prostate Cancer, Prostatic Neoplasms
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Hematology Oncology Associates, PC
    New Mexico Cancer Care Associates
    Prostate Cancer
    A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

    Albuquerque, New Mexico 87131-5636
    Advanced Liposarcoma or Leiomyosarcoma
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Lovelace Medical Center - Downtown
    Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
    University of New Mexico Cancer Center - South
    Cancer